Treatment of Raynaud's phenomenon by fibrinolytic enhancement.

@article{Jarrett1978TreatmentOR,
  title={Treatment of Raynaud's phenomenon by fibrinolytic enhancement.},
  author={P. E. M. Jarrett and Michelle Morland and Norman L. Browse},
  journal={British medical journal},
  year={1978},
  volume={2 6136},
  pages={
          523-5
        }
}
Twenty patients with advanced Raynaud's phenomenon, in 14 of whom it was secondary to scleroderma, were treated with stanozolol, an anabolic steroid that enhances natural fibrinolysis. All showed an increase in hand blood flow and a reduction in symptoms during treatment. This response may have been caused by the lysis of fibrin deposited in the digital arteries and the reduction of plasma viscosity. Stanozolol is a useful addition to the treatment of patients with advanced Raynaud's phenomenon… CONTINUE READING
BETA

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 15 CITATIONS

Pathogenesis and treatment of Raynaud's phenomenon

  • Cardiovascular Drugs and Therapy
  • 1990
VIEW 1 EXCERPT
CITES METHODS

Management of Raynaud’s Phenomenon

VIEW 2 EXCERPTS
CITES METHODS

Similar Papers

Loading similar papers…